Certified by Founder
Lodge
Outrun Therapeutics
start up
United Kingdom
- Dundee, Scotland
- 19/04/2024
- Seed
- $10,000,000
Outrun Therapeutics is unlocking the therapeutic potential of protein stabilisation by E3 Ligase inhibition for the treatment of cancer and other diseases.
- Industry Biotechnology Research
- Website https://outruntx.com/
- LinkedIn https://www.linkedin.com/company/outrun-therapeutics/
Related People
Carolyn PorterFounder
United Kingdom -
Greater Oxford Area
25 years of leadership experience, including in the spin-out arena, having led the formation of 16 companies raising £52M cumulatively in seed financing while at Oxford University. Held Board positions in several biotech companies and formerly held Business Development roles in big pharma (Novartis) and big biotech(Chiron).
Specialties: Key skills include business development, deal negotiation and execution, strategic, market and business analysis, people management and project management.
Tribe Stays | $2,800,000 | (Nov 18, 2025)
No Barrier Medical Translation | $2,700,000 | (Nov 18, 2025)
PowerLattice | $25,000,000 | (Nov 18, 2025)
Shipday | $7,000,000 | (Nov 18, 2025)
Muse Software | $4,500,000 | (Nov 18, 2025)
Artios | $115,000,000 | (Nov 18, 2025)
Scripta Therapeutics | $12,000,000 | (Nov 18, 2025)
Self Labs | $9,000,000 | (Nov 18, 2025)
Obello | $8,500,000 | (Nov 18, 2025)
AlertD | $3,000,000 | (Nov 18, 2025)
Skeletalis, Inc. | $8,000,000 | (Nov 18, 2025)
Span(US) | $25,000,000 | (Nov 18, 2025)